Febrile Illness

A study of more than 2,600 U.S. adults found “generally low rates” of COVID-19 testing among participants reporting onset of febrile illness through late October 2020, according to results published in JAMA Network Open.

Researchers uncovered what they called “an enormous burden of dengue fever among children with undifferentiated febrile illness in Kenya.”

Testing for Heartland virus disease should be part of the evaluation for patients who have an acute febrile illness with either leukopenia or thrombocytopenia that cannot explained by another condition or when a tick-borne disease is suspected, but there was no improvement after appropriate treatment, according to a review of the virus’s epidemiology.

Levofloxacin prophylaxis during the first few months of active myeloma treatment significantly reduced febrile episodes and mortality compared with placebo among a cohort of U.K. patients with newly diagnosed myeloma, according to results of the randomized phase 3 TEAMM study published in The Lancet Oncology.